Cargando…
Is There a Difference in Microbiological Epidemiology and Effective Empiric Antimicrobial Therapy Comparing Fracture-Related Infection and Periprosthetic Joint Infection? A Retrospective Comparative Study
This study aims to investigate (1) microbial patterns in fracture-related infections (FRIs) in comparison to microbiological patterns of periprosthetic joint infections (PJIs), (2) the identification of effective empiric antibiotic therapy for FRIs and PJIs and (3) analysis of difficult-to-treat (DT...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388716/ https://www.ncbi.nlm.nih.gov/pubmed/34438971 http://dx.doi.org/10.3390/antibiotics10080921 |
_version_ | 1783742700562939904 |
---|---|
author | Rupp, Markus Baertl, Susanne Walter, Nike Hitzenbichler, Florian Ehrenschwender, Martin Alt, Volker |
author_facet | Rupp, Markus Baertl, Susanne Walter, Nike Hitzenbichler, Florian Ehrenschwender, Martin Alt, Volker |
author_sort | Rupp, Markus |
collection | PubMed |
description | This study aims to investigate (1) microbial patterns in fracture-related infections (FRIs) in comparison to microbiological patterns of periprosthetic joint infections (PJIs), (2) the identification of effective empiric antibiotic therapy for FRIs and PJIs and (3) analysis of difficult-to-treat (DTT) pathogens. Patients treated for FRIs or PJIs from 2017 to 2020 were evaluated for pathogens detected during treatment. Antibiotic susceptibility profiles were examined with respect to broadly used antibiotics and antibiotic combinations. Resistance rates to rifampicin or fluoroquinolone were determined. A total of 81 patients with PJI and 86 with FRI were included in the study. For FRIs Staphylococcus aureus was the most common infection-causing pathogen (37.4% vs. 27.9% for PJI). Overall, there was no statistical difference in pathogen distribution (p = 0.254). For FRIs, combinations of gentamicin + vancomycin (93.2%), co-amoxiclav + glycopeptide and meropenem + vancomycin (91.9% each) would have been effective for empiric therapy, similar to PJIs. Difficult to treat pathogens were more frequently detectable in PJIs (11.6% vs. 2.3%). Empiric therapy combinations such as gentamicin + vancomycin, co-amoxiclav + glycopeptide or meropenem + vancomycin, are effective antibiotic strategies for both FRI and PJI patients. More DTT pathogens were detectable in PJIs compared to FRIs. |
format | Online Article Text |
id | pubmed-8388716 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-83887162021-08-27 Is There a Difference in Microbiological Epidemiology and Effective Empiric Antimicrobial Therapy Comparing Fracture-Related Infection and Periprosthetic Joint Infection? A Retrospective Comparative Study Rupp, Markus Baertl, Susanne Walter, Nike Hitzenbichler, Florian Ehrenschwender, Martin Alt, Volker Antibiotics (Basel) Article This study aims to investigate (1) microbial patterns in fracture-related infections (FRIs) in comparison to microbiological patterns of periprosthetic joint infections (PJIs), (2) the identification of effective empiric antibiotic therapy for FRIs and PJIs and (3) analysis of difficult-to-treat (DTT) pathogens. Patients treated for FRIs or PJIs from 2017 to 2020 were evaluated for pathogens detected during treatment. Antibiotic susceptibility profiles were examined with respect to broadly used antibiotics and antibiotic combinations. Resistance rates to rifampicin or fluoroquinolone were determined. A total of 81 patients with PJI and 86 with FRI were included in the study. For FRIs Staphylococcus aureus was the most common infection-causing pathogen (37.4% vs. 27.9% for PJI). Overall, there was no statistical difference in pathogen distribution (p = 0.254). For FRIs, combinations of gentamicin + vancomycin (93.2%), co-amoxiclav + glycopeptide and meropenem + vancomycin (91.9% each) would have been effective for empiric therapy, similar to PJIs. Difficult to treat pathogens were more frequently detectable in PJIs (11.6% vs. 2.3%). Empiric therapy combinations such as gentamicin + vancomycin, co-amoxiclav + glycopeptide or meropenem + vancomycin, are effective antibiotic strategies for both FRI and PJI patients. More DTT pathogens were detectable in PJIs compared to FRIs. MDPI 2021-07-29 /pmc/articles/PMC8388716/ /pubmed/34438971 http://dx.doi.org/10.3390/antibiotics10080921 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Rupp, Markus Baertl, Susanne Walter, Nike Hitzenbichler, Florian Ehrenschwender, Martin Alt, Volker Is There a Difference in Microbiological Epidemiology and Effective Empiric Antimicrobial Therapy Comparing Fracture-Related Infection and Periprosthetic Joint Infection? A Retrospective Comparative Study |
title | Is There a Difference in Microbiological Epidemiology and Effective Empiric Antimicrobial Therapy Comparing Fracture-Related Infection and Periprosthetic Joint Infection? A Retrospective Comparative Study |
title_full | Is There a Difference in Microbiological Epidemiology and Effective Empiric Antimicrobial Therapy Comparing Fracture-Related Infection and Periprosthetic Joint Infection? A Retrospective Comparative Study |
title_fullStr | Is There a Difference in Microbiological Epidemiology and Effective Empiric Antimicrobial Therapy Comparing Fracture-Related Infection and Periprosthetic Joint Infection? A Retrospective Comparative Study |
title_full_unstemmed | Is There a Difference in Microbiological Epidemiology and Effective Empiric Antimicrobial Therapy Comparing Fracture-Related Infection and Periprosthetic Joint Infection? A Retrospective Comparative Study |
title_short | Is There a Difference in Microbiological Epidemiology and Effective Empiric Antimicrobial Therapy Comparing Fracture-Related Infection and Periprosthetic Joint Infection? A Retrospective Comparative Study |
title_sort | is there a difference in microbiological epidemiology and effective empiric antimicrobial therapy comparing fracture-related infection and periprosthetic joint infection? a retrospective comparative study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388716/ https://www.ncbi.nlm.nih.gov/pubmed/34438971 http://dx.doi.org/10.3390/antibiotics10080921 |
work_keys_str_mv | AT ruppmarkus isthereadifferenceinmicrobiologicalepidemiologyandeffectiveempiricantimicrobialtherapycomparingfracturerelatedinfectionandperiprostheticjointinfectionaretrospectivecomparativestudy AT baertlsusanne isthereadifferenceinmicrobiologicalepidemiologyandeffectiveempiricantimicrobialtherapycomparingfracturerelatedinfectionandperiprostheticjointinfectionaretrospectivecomparativestudy AT walternike isthereadifferenceinmicrobiologicalepidemiologyandeffectiveempiricantimicrobialtherapycomparingfracturerelatedinfectionandperiprostheticjointinfectionaretrospectivecomparativestudy AT hitzenbichlerflorian isthereadifferenceinmicrobiologicalepidemiologyandeffectiveempiricantimicrobialtherapycomparingfracturerelatedinfectionandperiprostheticjointinfectionaretrospectivecomparativestudy AT ehrenschwendermartin isthereadifferenceinmicrobiologicalepidemiologyandeffectiveempiricantimicrobialtherapycomparingfracturerelatedinfectionandperiprostheticjointinfectionaretrospectivecomparativestudy AT altvolker isthereadifferenceinmicrobiologicalepidemiologyandeffectiveempiricantimicrobialtherapycomparingfracturerelatedinfectionandperiprostheticjointinfectionaretrospectivecomparativestudy |